Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00104442
Status:
COMPLETED
Last Update Posted:
2007-12-21
First Post:
2005-02-28
Brief Title:
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimers Disease
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Alzheimers disease is a medical illness that damages the brain and causes problems with memory mood and behavior A substance called acetylcholine ACh which is naturally produced in the body plays an important role in the normal functioning of the brain In subjects with Alzheimers disease the level of ACh is greatly reduced Currently there are three commonly prescribed drugs used for treating the symptoms of Alzheimers disease by helping to maintain the level of ACh in the brain This study will evaluate how much each of these drugs changes the levels of certain brain chemicals that are known to or may play an important role in Alzheimers disease and its symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None